{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T21:38:21Z","timestamp":1761946701340,"version":"3.44.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.jns.2006.10.005","type":"journal-article","created":{"date-parts":[[2006,11,28]],"date-time":"2006-11-28T10:30:53Z","timestamp":1164709853000},"page":"45-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Serum levels of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in subacute sclerosing panencephalitis"],"prefix":"10.1016","volume":"252","author":[{"given":"Takashi","family":"Ichiyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Siba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dagwin","family":"Suarkia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Takasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Miki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryutaro","family":"Kira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Kusuhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiro","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Toyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2006.10.005_bib1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-5728(96)00179-8","article-title":"Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview","volume":"72","author":"Chandler","year":"1997","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2006.10.005_bib2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1023\/A:1026028303196","article-title":"Regulation of matrix metalloproteinases: an overview","volume":"253","author":"Chakraborti","year":"2003","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jns.2006.10.005_bib3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF02821717","article-title":"Extracellular matrix degradation by metalloproteinases and central nervous system diseases","volume":"19","author":"Lukes","year":"1999","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.jns.2006.10.005_bib4","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0945-053X(97)90025-1","article-title":"Relating matrix metalloproteinase structure to function: why the \u201chemopexin\u201d domain?","volume":"15","author":"Murphy","year":"1997","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jns.2006.10.005_bib5","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1172\/JCI118286","article-title":"IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes","volume":"96","author":"Lacraz","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jns.2006.10.005_bib6","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1212\/WNL.53.7.1397","article-title":"Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis","volume":"53","author":"Waubant","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2006.10.005_bib7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0165-5728(03)00006-7","article-title":"Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes","volume":"136","author":"Avolio","year":"2003","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2006.10.005_bib8","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00415-003-0110-8","article-title":"Serum gelatinase B\/MMP-9 in primary progressive multiple sclerosis patients treated with interferon-beta-1\u03b1","volume":"250","author":"Dubois","year":"2003","journal-title":"J Neurol"},{"key":"10.1016\/j.jns.2006.10.005_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1212\/WNL.60.1.52","article-title":"IFN\u03b2 lowers MMP-9\/TIMP-1 ratio, which predicts new enhancing lesions in patients with SPMS","volume":"60","author":"Waubant","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2006.10.005_bib10","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1007\/s00415-003-0191-4","article-title":"Interferon-\u03b2-1 b decreased matrix metalloproteinase-9 serum levels in primary progressive multiple sclerosis","volume":"250","author":"Yushchenko","year":"2003","journal-title":"J Neurol"},{"key":"10.1016\/j.jns.2006.10.005_bib11","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jneuroim.2004.05.005","article-title":"Changes of matrix metalloproteinase-9 and its tissue inhibitor (TIMP-1) after autologous hematopoietic stem cell transplantation in multiple sclerosis","volume":"153","author":"Blanco","year":"2004","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2006.10.005_bib12","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00415-004-0285-7","article-title":"Effect of interferon \u03b2-1a on serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in relapsing remitting multiple sclerosis patients. One year follow-up results","volume":"251","author":"Karabudak","year":"2004","journal-title":"J Neurol"},{"key":"10.1016\/j.jns.2006.10.005_bib13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jneuroim.2003.10.046","article-title":"Increase of matrix metalloproteinase-9 in peripheral blood of multiple sclerosis patients treated with high doses of methylprednisolone","volume":"146","author":"Mirowska","year":"2004","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2006.10.005_bib14","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1191\/1352458504ms1058oa","article-title":"Decreased MMP-9 production in primary progressive multiple sclerosis patients","volume":"10","author":"Sastre-Garriga","year":"2004","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2006.10.005_bib15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jneuroim.2005.02.001","article-title":"Gelatinases (MMP-2 and MMP-9) are preferentially expressed by Th1 vs. Th2 cells","volume":"163","author":"Abraham","year":"2005","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2006.10.005_bib16","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0140-6736(05)61008-2","article-title":"Matrix metalloproteinases biomarkers in multiple sclerosis","volume":"365","author":"Rosenberg","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2006.10.005_bib17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1196\/annals.1322.014","article-title":"Angiogenesis in neuroblastoma","volume":"1028","author":"Ribatti","year":"2004","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.jns.2006.10.005_bib18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jns.2004.11.041","article-title":"Matrix metalloproteinase-9 in cerebral-amyloid-angiopathy-related hemorrhage","volume":"229\u2013230","author":"Lee","year":"2005","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2006.10.005_bib19","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jneuroim.2005.10.010","article-title":"Serum levels of matrix metalloproteinase-9 and its tissue inhibitor (TIMP-1) in acute disseminated encephalomyelitis","volume":"172","author":"Ichiyama","year":"2006","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2006.10.005_bib20","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1017\/S0950268800050044","article-title":"Subacute sclerosing panencephalitis (SSPE) in Papua New Guinea: a high incidence in young children","volume":"108","author":"Lucas","year":"1992","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jns.2006.10.005_bib21","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1017\/S0950268803008999","article-title":"A continuing high incidence of subacute sclerosing panencephalitis (SSPE) in the Eastern Highlands of Papua New Guinea","volume":"131","author":"Takasu","year":"2003","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jns.2006.10.005_bib22","first-page":"585","article-title":"Subacute sclerosing panencephalitis surveillance - United States","volume":"31","author":"CDC","year":"1982","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jns.2006.10.005_bib23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0733-8619(18)31062-4","article-title":"Subacute sclerosing panencephalitis. Current status","volume":"3","author":"Dyken","year":"1985","journal-title":"Neurol Clin"},{"key":"10.1016\/j.jns.2006.10.005_bib24","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/0140-6736(90)93398-9","article-title":"SSPE in the developing world","volume":"336","author":"Editorial","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2006.10.005_bib25","first-page":"493","article-title":"SSPE: clinical staging, course, and frequency, 1975","volume":"32","author":"Jabbour","year":"1975","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2006.10.005_bib26","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1212\/WNL.48.4.1142","article-title":"Subacute sclerosing panencephalitis","volume":"48","author":"Ichiyama","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2006.10.005_bib27","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/infdis\/175.3.689","article-title":"Increased levels of interleukin-1\u03b2 and soluble intercellular adhesion molecule-1 in cerebrospinal fluid of patients with subacute sclerosing panencephalitis","volume":"175","author":"Mehta","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jns.2006.10.005_bib28","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1177\/088307389901400702","article-title":"Lymphocyte subsets and inflammatory mediators in patients with subacute sclerosing panencephalitis","volume":"14","author":"Tekg\u00fcl","year":"1999","journal-title":"J Child Neurol"},{"key":"10.1016\/j.jns.2006.10.005_bib29","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/088307380101600606","article-title":"Interleukin-1\u03b2, interleukin-1 receptor antagonist levels in patients with subacute sclerosing panencephalitis and the effects of different treatment protocols","volume":"16","author":"Haspolat","year":"2001","journal-title":"J Child Neurol"},{"key":"10.1016\/j.jns.2006.10.005_bib30","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/13550280590901769","article-title":"Detection of interleukin 10 in cerebrospinal fluid of patients with subacute sclerosing panencephalitis","volume":"11","author":"Mistchenko","year":"2005","journal-title":"J NeuroVirol"},{"key":"10.1016\/j.jns.2006.10.005_bib31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cyto.2005.11.009","article-title":"Analysis of serum and cerebrospinal fluid cytokine levels in subacute sclerosing panencephalitis in Papua New Guinea","volume":"33","author":"Ichiyama","year":"2006","journal-title":"Cytokine"},{"key":"10.1016\/j.jns.2006.10.005_bib32","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1172\/JCI114867","article-title":"Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development","volume":"186","author":"Welgus","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jns.2006.10.005_bib33","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.4049\/jimmunol.154.9.4379","article-title":"T cell gelatinases mediate basement membrane transmigration in vitro","volume":"154","author":"Leppert","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.jns.2006.10.005_bib34","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1212\/WNL.46.6.1626","article-title":"Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury","volume":"46","author":"Rosenberg","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2006.10.005_bib35","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0304-3940(95)12173-0","article-title":"Matrix metalloproteinases degrade myelin basic protein","volume":"201","author":"Chandler","year":"1995","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jns.2006.10.005_bib36","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0165-5728(00)00225-3","article-title":"The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system","volume":"107","author":"Hartung","year":"2000","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2006.10.005_bib37","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1093\/brain\/124.11.2203","article-title":"T-cell- and macrophage-mediated axon damage in the absence of a CNS-specific immune response: involvement of metalloproteinases","volume":"124","author":"Newman","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.jns.2006.10.005_bib38","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1177\/088307380101601206","article-title":"Tissue inflammatory response in subacute sclerosing panencephalitis (SSPE)","volume":"16","author":"Anlar","year":"2001","journal-title":"J Child Neurol"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X06004813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X06004813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:37:40Z","timestamp":1758382660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X06004813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0022510X06004813"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2006.10.005","relation":{},"ISSN":["0022-510X"],"issn-type":[{"type":"print","value":"0022-510X"}],"subject":[],"published":{"date-parts":[[2007,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum levels of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in subacute sclerosing panencephalitis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2006.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}